abrdn Life Sciences Investors
HQL- Exchange
- NYSE
- SEC CIK
- 0000884121
In the last 90 days, abrdn Life Sciences Investors insiders filed 1 open-market purchase and 0 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $156.5M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding abrdn Life Sciences Investors changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 64 | 67 | +3 |
| Shares | 4.76M | 4.40M | −355.2K (−7.5%) |
| Value | $93.8M | $94.2M | +$468.7K (+0.5%) |
New holders (11)
Institutions that held abrdn Life Sciences Investors at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. | 11,808 | $253.0K | 0.00% |
| Mid Atlantic Financial Management Inc | 10,700 | $229.0K | 0.02% |
| Change Path, LLC | 10,539 | $226.0K | 0.01% |
| Wedbush Securities Inc | 10,103 | $217.0K | 0.01% |
| Creative Planning | 9,919 | $213.0K | 0.00% |
| Stratos Wealth Partners, LTD. | 9,804 | $210.0K | 0.01% |
| Advisory Services Network, LLC | 2,685 | $58.0K | 0.00% |
| Meeder Asset Management Inc | 1,840 | $39.0K | 0.00% |
| West Branch Capital LLC | 630 | $13.0K | 0.01% |
| Credit Suisse AG | 10,000 | $10.0K | 0.00% |
| Wealth Quarterback LLC | 50 | $2.00K | 0.00% |
Sold out (8)
Institutions that held abrdn Life Sciences Investors at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Shepherd Kaplan Krochuk, LLC | 13,290 | $262.0K |
| Eudaimonia Partners, LLC | 6,729 | $133.0K |
| Princeton Global Asset Management LLC | 1,251 | $25.0K |
| Selective Wealth Management, Inc. | 667 | $13.0K |
| Simon Quick Advisors, LLC | 300 | $5.00K |
| JPMorgan Chase & Co | 3 | $0 |
| FMR LLC | 1 | $0 |
| Northwestern Mutual Wealth Management Co | 9 | $0 |